Search

Author/Creator Checketts, Daniel

1. Add‐on cannabidiol in patients with Dravet syndrome: Results of a long‐term open‐label extension trial. (18th August 2021)

Authors:
Scheffer, Ingrid E.; Halford, Jonathan J.; Miller, Ian; Nabbout, Rima; Sanchez‐Carpintero, Rocio; Shiloh‐Malawsky, Yael; Wong, Matthew; Zolnowska, Marta; Checketts, Daniel; Dunayevich, Eduardo; Devinsky, Orrin
Journal:
Epilepsia
Issue:
Volume 62:issue 10(2021)
Page Start:
2505
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant epilepsies: Four‐year results from the expanded access program. Issue 3 (10th January 2023)

Authors:
Szaflarski, Jerzy P.; Devinsky, Orrin; Lopez, Merrick; Park, Yong D.; Zentil, Pilar Pichon; Patel, Anup D.; Thiele, Elizabeth A.; Wechsler, Robert T.; Checketts, Daniel; Sahebkar, Farhad
Journal:
Epilepsia
Issue:
Volume 64:Issue 3(2023)
Page Start:
619
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Long‐term safety and efficacy of add‐on cannabidiol in patients with Lennox–Gastaut syndrome: Results of a long‐term open‐label extension trial. (20th July 2021)

Authors:
Patel, Anup D.; Mazurkiewicz‐Bełdzińska, Maria; Chin, Richard F.; Gil‐Nagel, Antonio; Gunning, Boudewijn; Halford, Jonathan J.; Mitchell, Wendy; Scott Perry, Michael; Thiele, Elizabeth A.; Weinstock, Arie; Dunayevich, Eduardo; Checketts, Daniel; Devinsky, Orrin
Journal:
Epilepsia
Issue:
Volume 62:issue 9(2021)
Page Start:
2228
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Long‐term safety and treatment effects of cannabidiol in children and adults with treatment‐resistant epilepsies: Expanded access program results. (12th July 2018)

Authors:
Szaflarski, Jerzy P.; Bebin, Elizabeth Martina; Comi, Anne M.; Patel, Anup D.; Joshi, Charuta; Checketts, Daniel; Beal, Jules C.; Laux, Linda C.; De Boer, Lisa M.; Wong, Matthew H.; Lopez, Merrick; Devinsky, Orrin; Lyons, Paul D.; Zentil, Pilar Pichon; Wechsler, Robert
Other Names:
Chez Michael investigator.; Flamini Robert investigator.; Marsh Eric D. investigator.; Miller Ian investigator.; Park Yong investigator.; Segal Eric investigator.; Seltzer Laurie investigator.; Thiele Elizabeth A. investigator.; Weinstock Arie investigator.
Journal:
Epilepsia
Issue:
Volume 59:issue 8(2018)
Page Start:
1540
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Time to onset of cannabidiol (CBD) treatment effect in Lennox–Gastaut syndrome: Analysis from two randomized controlled trials. (2nd April 2021)

Authors:
Privitera, Michael; Bhathal, Hari; Wong, Matthew; Cross, J. Helen; Wirrell, Elaine; Marsh, Eric D.; Mazurkiewicz‐Beldzinska, Maria; Villanueva, Vicente; Checketts, Daniel; Knappertz, Volker; VanLandingham, Kevan
Journal:
Epilepsia
Issue:
Volume 62:issue 5(2021)
Page Start:
1130
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6. Issue 5 (4th March 2022)

Authors:
Wu, Joyce Y.; Cock, Hannah R.; Devinsky, Orrin; Joshi, Charuta; Miller, Ian; Roberts, Colin M.; Sanchez‐Carpintero, Rocio; Checketts, Daniel; Sahebkar, Farhad
Journal:
Epilepsia
Issue:
Volume 63:Issue 5(2022)
Page Start:
1189
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗